Triptorelin acetate(57773-63-4 free base) NEW
| Price | $50 | $75 | $128 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-05-09 |
Product Details
| Product Name: Triptorelin acetate(57773-63-4 free base) | CAS No.: 140194-24-7 |
| Purity: 99.90% | Supply Ability: 10g |
| Release date: 2025/05/09 |
Product Introduction
Bioactivity
| Name | Triptorelin acetate(57773-63-4 free base) |
| Description | Triptorelin acetate(57773-63-4 free base) (CL 118,532) is used as a GnRH agonist. It decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by causing constant stimulation of the pituitary. Triptorelin acetate(57773-63-4 free base) may be used in the treatment of hormone-responsive cancers such as breast cancer or prostate cancer, precocious puberty, estrogen-dependent conditions, and assisted reproduction. |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : Insoluble DMSO : 65 mg/mL (47.39 mM), Sonication is recommended. |
| Keywords | Triptorelin acetate(57773-63-4 free base) | Triptorelin acetate(57773634 free base) | Triptorelin acetate(57773 63 4 free base) | GNRHReceptor | GNRHR | GNRH Receptor | CL-118532 | CL118532 | BIM-21003 | BIM21003 | AY-25650 | AY25650 |
| Inhibitors Related | Histrelin acetate | Cetrorelix Acetate | Relugolix | Deslorelin acetate(57773-65-6 free base) | Opigolix | Goserelin acetate | Linzagolix choline | LGnRH-III, lamprey acetate(147859-97-0 free base) | Alarelin Acetate | Cetrorelix diacetate | Lecirelin acetate(61012-19-9 free base) | AG 045572 |
| Related Compound Libraries | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Peptide Compound Library | Anti-Viral Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1Box |
VIP1Y
|
American HealthyMorph LLC
|
2024-11-29 | |
| $0.00/1box |
VIP1Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2024-10-30 | |
| $1335.00/1g |
VIP3Y
|
Hebei Dangtong Import and export Co LTD
|
2024-09-13 | |
| $3.20/2mg |
VIP1Y
|
Hebei Ganmiao New material Technology Co., LTD
|
2024-06-27 | |
| $16.00/1Box |
VIP1Y
|
Qingdao Xinli Technology Development Co., Ltd.
|
2024-05-30 | |
| $0.10/20mg |
VIP1Y
|
Shanghai Likang New Materials Co., Limited
|
2024-05-28 | |
| $0.00/1box |
Shanghai Affida new material science and technology center
|
2024-05-28 | ||
| $80.00/1box |
VIP1Y
|
Strong peptide cross-border e-commerce Co. LTD
|
2024-05-23 | |
| $25.00/1box |
Shanghai Getian Industrial Co., LTD
|
2024-04-29 | ||
| $0.00/1kg |
VIP2Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-16 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY